R. Scott McClelland, MD, MPH

Professor of Medicine (AID), Epidemiology, and Global Health

 

Dr. Scott McClelland, MPH, MD, is a Professor of Medicine in the Division of Allergy and Infectious Diseases at the University of Washington. He holds joint appointments in the Departments of Epidemiology and Global Health, and is a member of the University of Nairobi STD/HIV/sexual and reproductive health (SRH) Research Group. Dr. McClelland is a co-Principal Investigator for the University of Washington Vaccine and Treatment Evaluation Unit (VTEU), which includes sites in Seattle, Kenya, South Africa, and Peru. The VTEU conducts non-HIV clinical trials including those directed at pandemic response, respiratory viruses, neglected tropical diseases, malaria, enteric infections, and STIs. Dr. McClelland’s primary research interest focuses on the intersection between infectious diseases and women’s reproductive health. Methodologically, his work spans clinical trials, mHealth interventions, observational epidemiological studies, and implementation research.

Publications

  1. de Los Rios Kobara, I, Mangalanathan, U, Deline-Caballero, S, Pinedo, K, Stabile, M, Espinosa Bernal, CA et al.. Viral load-driven systemic immune exhaustion is an enabler of antibody breadth in HIV infection. bioRxiv. 2026; :. doi: 10.64898/2026.06.05.730519. PubMed PMID:42327147 PubMed Central PMC13278038.
  2. Aluisio, AR, Loevinsohn, G, Chondo, E, Nderitu, A, Bruba, M, Adam, A et al.. Correction: Study protocol for the: HIV enhanced access testing in emergency department program using a systems analysis and improvement approach (HEATED-SAIA) cluster randomized trial. Implement Sci Commun. 2026;7 (1):. doi: 10.1186/s43058-026-01019-5. PubMed PMID:42310802 PubMed Central PMC13274090.
  3. Aluisio, AR, Loevinsohn, G, Chondo, E, Nderitu, A, Bruba, M, Adam, A et al.. Study protocol for the: HIV enhanced access testing in emergency department program using a systems analysis and improvement approach (HEATED-SAIA) cluster randomized trial. Implement Sci Commun. 2026;7 (1):. doi: 10.1186/s43058-026-00964-5. PubMed PMID:42157232 PubMed Central PMC13214408.
  4. Barnabas, RV, Brown, ER, Bukusi, EA, Njoroge, B, Winer, RL, Galloway, DA et al.. Efficacy and durability of immediate versus delayed single-dose HPV vaccination for persistent infection among young women in Kenya: a randomized, blinded, cross-over clinical trial. Nat Commun. 2026; :. doi: 10.1038/s41467-026-72654-8. PubMed PMID:42115165 .
  5. Heller, KB, Mohamed, JS, Cherne, SL, Onono, M, Bukusi, EA, Njoroge, BW et al.. High agreement of Seegene Anyplex™ HPV 28 and Allplex™ HPV 28 for high-risk vaccine-type HPV detection in the KEN SHE Study. J Virol Methods. 2026;344 :115395. doi: 10.1016/j.jviromet.2026.115395. PubMed PMID:41962590 .
Search PubMed